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Structural Basis of the Highly Efficient Trapping
of the HIV Tat Protein by an RNA Aptamer
and type 2 (HIV-2) are shown in Figures 1A and 1B,
respectively. The loop sequences are critical for the
transcriptional activation but do not affect the binding
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An RNA aptamer that binds Tat 100 times more
strongly than the authentic TAR was isolated by means
of the in vitro selection method [21]. The sequence of theSummary
aptamer implies the existence of two nearly symmetrical
Tat binding sites (boxed regions) that are found in TARAn RNA aptamer containing two binding sites exhibits
RNAs (Figures 1C and 1D). The sequence of the hairpinextremely high affinity to the HIV Tat protein. We have
at the top of the aptamer was originally UUUGC. In orderdetermined the structure of the aptamer complexed
to stabilize the structure, that sequence was replacedwith two argininamide molecules. Two adjacent U:A:U
by a GAAA sequence, which is known to form a stablebase triples were formed, which widens the major
tetranucleotide loop structure [22]. The aptamer com-groove to make space for the two argininamide mole-
peted efficiently for the binding of Tat in the presencecules. The argininamide molecules bind to the G bases
of a large excess of TAR of either HIV-1 or HIV-2 in vitrothrough hydrogen bonds. The binding is stabilized
[23]. The aptamer specifically prevents Tat-dependentthrough stacking interactions. The structure of the ap-
trans-activation both in vitro and in vivo [23]. Moreover,tamer complexed with a Tat-derived arginine-rich pep-
unlike TAR, the affinity of the aptamer to Tat does nottide was also characterized. It was suggested that the
depend on cellular proteins such as cyclin T1 [23]. Thus,aptamer structure is similar for both complexes and
the aptamer has the potential for use as a decoy mole-that the aptamer interacts with two different arginine
cule in gene therapy.residues of the peptide simultaneously at the two bind-
The dissociation constant (Kd) of the aptamer-Tating sites, which could explain the high affinity to Tat.
complex is 1010 M. The Kd of the complex between the
aptamer and the partial peptide spanning the arginine-
Introduction rich region of Tat, RKKRRQRRRPPQG (RG peptide), is
109 M, the decrease in affinity being only one order. In
The Tat protein of the human immunodeficiency virus order to elucidate the structural basis of the extremely
(HIV) plays a crucial role in viral replication [1–3]. Tat high affinity of the aptamer to Tat, the structure of the
stimulates transcription of the viral genome through aptamer complexed with argininamide, the simplest an-
binding to the trans-activating region (TAR) located at alog of Tat, has been determined by NMR. Unique struc-
the 5 end of all pre-messenger RNA transcripts [4]. A tural features responsible for the high affinity have been
small portion of TAR is responsible for transcriptional found: the formation of two adjacent U:A:U base triples,
activation and binding of Tat. The sequences of the the resultant widening of the major groove, the formation
essential portions of the TARs of HIV type 1 (HIV-1)
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Figure 2. Normalized Changes of Chemical Shifts as a Function of
the Molar Ratio of Argininamide to the Aptamer
Normalized changes for H5 (A) and H6 (B) at 35C and pH 6.5. Open
circles, C6; open triangles, U8; open squares, U11; open diamonds,
C13; closed circles, C14; closed triangles, C24; closed squares,
U27; closed diamonds, C30; and crosses, U31.
in fast exchange on the NMR time scale. The normalizedFigure 1. RNA Sequences
changes of the chemical shifts of either H5 or H6 reso-HIV-1 TAR (A); HIV-2 TAR (B); and RNA aptamer for the HIV Tat
nances (see the next section for assignments) are plot-protein (C). Postulated Tat binding sites are boxed. Expected base
pairs are indicated by dots. ted as a function of the molar ratio of argininamide to
(D) Comparison of the two binding sites, sites 1 (left) and 2 (right), the aptamer in Figure 2. For reference, the line joining
of the RNA aptamer. The orientation of site 2 is inverted compared (0, 0) and (2, 1) is drawn in Figures 2A and 2B. When all
to that in (C) for clarity. The formation of U:A:U base triples in the
data for both H5 (Figure 2A) and H6 (Figure 2B) arecomplex is indicated by arrows (see text).
taken into account together, the initial slopes of the
plots indicate that two argininamide molecules bind per
aptamer. This is as expected, because the base se-
quence of the aptamer implies the existence of twoof hydrogen bonds between a G base and argininamide,
binding sites.and the stabilization of the binding through stacking
interaction of a guanidinium group with bases. Structural
characterization of the aptamer complexed with the RG Assignment of Resonances of the
peptide has also been carried out. Simultaneous interac- Aptamer-Argininamide Complex
tions of the aptamer with two arginine residues of the Exchangeable 1H and Attached 15N Resonances
RG peptide at two binding sites are strongly suggested. of the Aptamer
A combination of structural studies on the aptamer- All imino proton-nitrogen correlation peaks expected for
argininamide and aptamer-RG peptide complexes pro- the base pairs illustrated in Figure 1C, that is, three A:U,
vides a comprehensive explanation of the extremely ten G:C, and one G:A base pairs, were observed on
high affinity of the aptamer to Tat. 1H-15N HSQC (Figure 3A). The correlation peaks originat-
ing from U and G residues were discriminated on the
basis of their 15N chemical sifts, 161–163 ppm for U andResults and Discussion
145–148 ppm for G. Observation of an upfield-shifted G
imino proton at 10.6 ppm is indicative of the formationStoichiometry of the Aptamer-Argininamide Complex
The formation of a complex between the aptamer and of the expected sheared G16:A19 base pair in the
G16A17A18A19 tetranucleotide loop. Thus, the iminoargininamide was monitored by tracing the H5-H6 corre-
lation peaks of the U and C residues of the aptamer in proton resonance of G16 is a good starting point for
the assignment. As shown in Figure 3B, imino protona series of TOCSY [24] spectra during titration. It turned
out that the free and bound forms of the aptamer were resonances were sequentially assigned from G16 to U11
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for the upper half of the aptamer, the overlapping of
the G15 and G21 resonances being resolved at higher
temperature. Sequential assignments from U27 to G1 were
also made for the lower half of the aptamer (Figure 3B).
Eleven pairs of amino proton-nitrogen correlation peaks
observed on 1H-15N HSQC were interpreted as those of
C residues due to their 15N chemical shifts of 94–100
ppm. Ten of the eleven pairs were assigned to specific
C residues on the basis of the NOESY [25] cross peaks
between a G imino proton and the C amino protons
for each G:C base pair. The remaining amino proton-
nitrogen pair was assigned to C24 automatically. Two
additional pairs of amino proton-nitrogen correlation
peaks observed on 1H-15N HSQC were interpreted as
those of G residues due to their 15N chemical shifts of
73–75 ppm. These pairs were assigned to G9 and G25,
respectively, on the basis of the intraresidue imino-
amino NOESY cross peak for each G residue. Finally,
another pair of amino proton-nitrogen correlation peaks
observed on 1H-15N HSQC was interpreted as that of an
A residue due to its 15N chemical shift of 84 ppm. This
was assigned to the overlapping of the amino proton-
nitrogen correlation peaks of A10 and A26, because of
the strong NOESY cross peaks between these amino
protons and the imino protons of U11 and U27.
Nonexchangeable 1H and Attached
13C Resonances
Nonexchangeable 1H resonances were assigned using
standard methods [26–28]. Figure 3C shows expansion
of the NOESY spectrum, which allows the sequential
assignments of H1 and H6/H8 through H1(i1)-H6/
H8(i)-H1(i) connectivities. When the sheared G:A base
pair is formed in the GAAA tetranucleotide loop, H1 of
the residue located next to the loop is upfield shifted
due to the ring current effect [22]. Observation of an
upfield-shifted C20H1 (3.65 ppm) is indicative of the
expected G16:A19 sheared base pair. H2, H3, H4, and
H5/5″ were assigned by means of HCCH-COSY [29]
and HCCH-TOCSY [30] spectra (Figure 3D), the 13C reso-
nances of sugars, C1, C2, C3, C4, and C5, being
assigned at the same time. Unambiguous assignments
of the H5/H5″ methylene protons were made by chang-
ing the delay time of reverse INEPT [31]. The assign-
ments were confirmed by successful tracing of the
H2(i1)-H6/H8(i)-H2(i) and H3(i1)-H6/H8(i)-H3(i)
connectivities (data not shown). The H3(i1)-P(i1)-
H4/H5/H5″(i) connectivities in the 1H-31P HetCor [32]
spectrum provide some additional confirmation of the
assignments (data not shown). AH2 was assigned from
with a mixing time of 200 ms at 1C and pH 6.5; the sequential
assignments are indicated. Cross peaks “across a bulge,” G29-G9
and G22-G25, are boxed. The G29-G9 cross peak indicated by a
dot becomes visible when the level of the plot is lowered.
(C) The H6/H8-H1/H5 region of the NOESY spectrum of the complex
with a mixing time of 200 ms at 35C and pH 6.5. The lines show
the H1(i1)-H6/H8(i)-H1(i) connectivities; the intraresidue H6/H8-
H1 cross peaks are labeled with their residue numbers. The C20H1-
C20H6 and C20H1-G21H8 cross peaks are outside of this region
Figure 3. Assignments of Resonances due to an extremely upfield-shifted C20H1 resonance.
(A) The imino proton-nitrogen region of the 1H-15N HSQC spectrum (D) The correlation from H1 to H2/H3/H4/H5/H5″ for the U7 and
of the aptamer-argininamide complex at 1C and pH 6.5; the assign- U23 residues in the HCCH-TOCSY spectrum of the complex with a
ments are labeled with the residue numbers. mixing time of 24.8 ms at 35C and pH 6.5. The H1-H2 and H1-
(B) The imino proton region of the NOESY spectrum of the complex H4 peaks of U23 are overlapping.
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the intraresidue correlation with AH8 in the HCCH-
TOCSY [33, 34] spectrum. Observation of strong NOESY
cross peaks between AH2 and UH3 for the A4:U31,
A10:U27, and A26:U11 base pairs (data not shown) fur-
ther confirmed the exchangeable and nonexchangeable
1H assignments. The 13C resonances of bases, C2, C5,
C6, and C8, were assigned based on the 1H-13C HSQC
spectrum. The appearance of the C5 resonances of U
residues (102–106 ppm) in the lower field region com-
pared to those of C residues (96–100 ppm) was consis-
tent with the general tendency [28]. Finally, the cross
peaks between UH3 and AN1, and those between GH1
and CN3 in the HNN-COSY [35, 36] spectrum, (data not
shown) confirmed the formation of the A:U and G:C
base pairs indicated in Figure 1, the assignments being
confirmed as well.
Resonances of Argininamide
H, H, H, H, H, and NH2 of argininamide in the
complex were assigned based on TOCSY spectra ob-
tained in 1H2O and 2H2O. An extra exchangeable proton
resonance was found in the 13C-, 15N-filtered NOESY
spectrum [37], which was assigned to the amide NH2
on the basis of the NOESY cross peak to H. An H	
resonance was not detected. The resonances of the two
argininamide molecules are almost identical, as ex-
pected from the nearly symmetrical base sequences of Figure 4. Chemical Shift Perturbations on Binding of Argininamide
the two binding sites. H5-H6 correlation peaks in the TOCSY spectrum (A) and H5-C5
correlation peaks in the 1H-13C HSQC spectrum (B) of the free (gray)
and argininamide-bound (black) aptamers at 25C and pH 6.5; the
Confirmation of the Existence of Two Binding assignments are labeled with the residue numbers.
Sites in the Aptamer
The existence of two binding sites, boxed in Figure 1C,
was predicted from the sequence of the aptamer. Large 2 occupied, both sites occupied, and both sites empty.
If these states are in fast exchange on the NMR timechemical shift perturbations upon binding of argininam-
ide of either the H5-H6 correlation peaks in the TOCSY scale, the experimental result can be explained. The
second explanation is that the binding of two argininam-spectrum (Figure 4A) or the H5-C5 correlation peaks in
the 1H-13C HSQC spectrum (Figure 4B) were observed ide molecules is completely cooperative. In this case,
at the 1:1 ratio, two states exist with nearly equal popula-for the C30, C6, U7, U8, C28, and U27 residues, and
also for the C14, C13, U23, C24, C12, and U11 ones. tion, both sites occupied and both sites empty. Again,
if these states are in fast exchange on the NMR timeLarge chemical shift perturbations of the H8-N7 correla-
tion peaks in the 1H-15N HSQC spectrum were observed scale, the experimental result can be explained. The
intermediate between the first and the second explana-for the G9 and A10 residues, and also for the G25 and
A26 residues (Figure 5B). The assignments of the ap- tions is also possible. The binding of argininamide to
the aptamer was monitored also by measuring a seriestamer in the free form were made on the basis of the
assignments for the complex form by tracing back the of circular dichroism spectra during the titration. Hill plot
analysis of these spectra did not indicate clear coopera-correlation peaks during the course of the titration, and
are utilized in these analyses. All of the perturbation tivity on the binding of argininamide (data not shown).
Therefore, the first explanation is favorable, althoughdata confirmed the existence of two binding sites. Here-
after, the lower and upper boxes in Figure 1C are named the existence of some cooperativity cannot be excluded
completely. In any case, when the excess amount ofbinding sites 1 and 2, respectively.
The normalized changes of the chemical shifts in- argininamide is supplied at the 1:4 ratio, both sites are
occupied for all aptamers in solution. The structuralcreased almost linearly up to the aptamer:argininamide
molar ratio of 1:1, which indicates that almost all argini- analysis was applied for this fully occupied form.
namide added bound to the aptamer up to the 1:1 ratio
under the high aptamer concentration employed for Formation of Two Adjacent U:A:U Base Triples
in the Aptamer-Argininamide ComplexNMR experiments. At the 1:1 ratio, the normalized
changes of the chemical shifts were ca. 0.5 for residues The proximity of the G29:C6 and G9:C28 base pairs was
indicated by the G29H1-G9H1 (boxed in Figure 3B) andof both sites 1 and 2 (Figure 2). Two explanations are
possible for this result. The first explanation is that the other NOESY cross peaks. The proximity of the G22:C13
and G25:C12 base pairs was also indicated by thebinding of two argininamide molecules is completely
independent and that two sites exhibit the similar affinity G22H1-G25H1 (boxed in Figure 3B) and other NOESY
cross peaks. These results imply the formation of twoto argininamide. In this case, at the 1:1 ratio, four differ-
ent states exist with nearly equal population: only site base triples, U7:A10:U27 and U23:A26:U11 (Figure 5A),
when the base triple formation observed in the TARs of1 of the aptamer occupied with argininamide, only site
Structures of RNA Aptamer-HIV Tat Analogs
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HIV-1, HIV-2, and BIV is recalled [12, 14–16, 19]. When
the U7:A10 and U23:A26 base pairs of the Hoogsteen
type are formed in addition to Watson-Crick A10:U27
and A26-U11 base pairs, the restriction of rotation
around a C6-N6 bond and/or the suppression of the
exchange of amino protons with solvent water are ex-
pected for the amino moieties of A10 and A26. Thus,
clear observation of amino proton-nitrogen correlation
peaks in the 1H-15N HSQC spectrum for A10 and A26
residues, correlation peaks for the other A residues not
being observed, is consistent with the formation of two
base triples in the complex.
An upfield shift of the N7 resonance upon complex
formation was observed for A10 and A26 (Figure 5B).
The chemical shift perturbations of the N7 resonances
of these A residues were larger than those of most other
residues. This is consistent with the formation of the
two U:A:U base triples, in which the N7 atoms of the
two A residues are acceptors of the hydrogen bonds.
Direct evidence of the formation of the two U:A:U
base triples was obtained by the detection of spin-spin
coupling across the hydrogen bond, 2hJNN. As imino pro-
ton resonances of either U7 or U23 were not observed,
probably due to exchange with solvent water, magneti-
zation originating from a nonexchangeable proton, AH8,
was used to detect 2hJNN in an HNN-COSY spectrum [38,
39]. The A10H8-U7N3 and A26H8-U23N3 cross peaks
in the HNN-COSY spectrum (Figure 5C) clearly confirm
the formation of the Hoogsteen A10:U7 and A26:U23
base pairs, respectively. The assignments of UN3 were
made based on intraresidue UH5-UN3 cross peaks in
the 1H-15N HSQC spectrum (data not shown). The A4H2-
U31N3, A10H2-U27N3, and A26H2-U11N3 cross peaks
(Figure 5C) are consistent with Watson-Crick A4:U31,
A10:U27 and A26:U11 base pairs, respectively. 2hJNN was
calculated on the basis of the intensity ratio of the diago-
nal to cross peaks in the HNN-COSY spectrum [35]. The
2hJNN between AN1 and UN3 for the three Watson-Crick
A:U base pairs was ca. 6 Hz. We have confirmed that the
same value was obtained in another kind of HNN-COSY
experiment in which the magnetization originating from
UH3 was used [35, 36]. The value of ca. 6 Hz is close
to those reported previously for the Watson-Crick A:U
base pairs in other RNA sequences, 7-8 Hz [35, 40]. The
2hJNN between AN7 and UN3 for the two Hoogsteen A:U
base pairs was ca. 4-5 Hz, which seems to be smaller
than those reported previously for the Hoogsteen A:T
base pairs of a DNA sequence, 6–8 Hz [41]. This may
reflect that the Hoogsteen A:U base pairs in the two
base triples dynamically open up for a certain period.
The formation of the U:A:U base triple for the HIV-1
TAR has been a matter of dispute [12–14]. The
HNN-COSY result clearly demonstrates the formation
Figure 5. Formation of U:A:U Base Triples of the two U:A:U base triples at least for the aptamer
(A) A scheme of the U:A:U base triple. complexed with argininamide molecules.
(B) AH2-AN1, AH2-AN3, and H8-N7 correlation peaks in the 1H-15N
HSQC spectrum of the free (light) and argininamide-bound aptamer
(dark) at 35C and pH 6.5. Peaks exhibiting large changes in the 15N
The Mode of Binding of an Argininamidechemical shift upon complex formation are labeled with their residue
Molecule to a G Basenumbers.
(C) The HNN-COSY spectrum of the aptamer complexed with argini- The chemical shift perturbations upon complex forma-
namide at 45C and pH 6.5. The AH2-UN3 and AH2-AN1 correlation tion of the N7 resonances of the G9, A10, G25, and A26
peaks for the Watson-Crick A:U base pairs, and the AH8-UN3 and residues were larger than those of other residues (Figure
AH8-AN7 correlation peaks for the Hoogsteen A:U base pairs are
5B). The large upfield shifts of the N7 resonances of thelabeled.
A10 and A26 residues were attributed to these N7 atoms
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being acceptors of the hydrogen bonds of the Hoog-
steen A:U base pairs in the complex. Similarly, the large
upfield shifts of the N7 resonances of the G9 and G25
residues suggest that these N7 atoms are acceptors of
the hydrogen bonds with argininamide molecules, as
illustrated in Figure 6A. The NOESY cross peaks be-
tween H/H/H of argininamide and the amino protons
of the C12 and C28 residues (data not shown), and those
between H/H/H and the imino protons of the G9
and G25 residues (Figure 6B) are consistent with the
formation of such hydrogen bonds. When either the G9
or G25 residue was replaced by a 7-deaza analog, the
affinity of the aptamer to an arginine-rich partial peptide
of the Tat protein decreased dramatically [23], which
constitutes another line of support of the formation of
the hydrogen bonds illustrated in Figure 6A.
The type of hydrogen bonds shown in Figure 6A is
widely observed when a G:C base pair is recognized by
an arginine residue [42, 43]. A similar type of hydrogen
bonds is observed in HIV-2 TAR complexed with argini-
namide [19], and BIV TAR complexed with an arginine-
rich peptide of BIV Tat [15], where the H	s of an arginine
residue are involved in the hydrogen bonds, whereas
H is not. An alternative type of hydrogen bonds is GO6-
H and GN7- H	, as observed in BIV TAR complexed
with an arginine-rich peptide of BIV Tat [16]. In this type,
H is close to the amino protons of a C residue base
paired to a G residue. The fact that an H-CNH2 NOE
was not observed in our case favors the type of hydro-
gen bonds shown in Figure 6A, in which H is far from
the amino protons.
Intermolecular NOEs between the Aptamer
and Argininamide
Intermolecular NOESY cross peaks between the imino
protons of the aptamer and H/H/H of argininamide
were observed for the G9, U27, and G29 residues of site
1 (Figure 6B). Similar cross peaks were observed for
G25, U11, and G22 of site 2 (Figure 6B). Intermolecular
NOESY cross peaks between amino protons and H/
H/H were identified for the A10, C28, and C6 residues
of site 1 in the 15N-edited NOESY spectrum with the aid
of separation in the 15N dimension (data not shown).
Similar cross peaks were identified for A26, C12, and
C13 of site 2 (data not shown). Intermolecular NOESY
cross peaks regarding H/H/H were identified addi-
tionally for H6/H8 of the C6 and U7 residues of site 1
(Figure 6C), for H5 of the C6, U7, U27, and C28 residues
of site 1 (Figure 6D), and for H2 and H3of the C6 residue
of site 1 (data not shown), with the aid of separation in
the 13C dimension in the 13C-edited NOESY spectrum in
some cases. Similar cross peaks were identified for H6/
Figure 6. Intermolecular ContactsH8 of G22 and U23 of site 2 (Figure 6C), for H5 of U23,
U11, and C12 of site 2 (Figure 6D), and for H2 and H3 A scheme of the binding of an argininamide molecule to the G
base of a G:C base pair (A). The intermolecular NOESY cross peaksof G22 of site 2 (data not shown). Intermolecular NOESY
between H/H/H of argininamide and imino protons of the ap-cross peaks with respect to  and amide NH2 of the
tamer in H2O at 1C (B), and those between H/H/H and H6/H8argininamide were observed for the imino protons of
(C) and H5 (D) of the aptamer in 2H2O at 35C.U27 of site 1 and U11 of site 2.
As mentioned above, intermolecular NOESY cross
peaks were observed for the C6:G29 and C13:G22 moie- to assume that two argininamide molecules bind to the
aptamer, one molecule to binding site 1 and the otherties. It is impossible for one argininamide molecule to
be close to the two separate moieties. It is reasonable molecule to binding site 2. This is consistent with the
Structures of RNA Aptamer-HIV Tat Analogs
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dues. The structural statistics of the 20 final structures
are presented in Table 1.
Structure of the Aptamer Complexed with Two
Argininamide Molecules
Figures 8A and 8B show stereo views of a representative
structure of the aptamer-argininamide complex with the
lowest energy among the 20 final structures. The ap-
tamer contains three stems, G1-C6:G29-C34, G9-
C12:G25-C28, and C13-G15:C20-G22 (Figure 1C). The
three stems are stacked on each other, which yields an
almost continuous double helix (Figure 8A). As a whole,
the structures of the two Tat binding sites are essentially
symmetric, as expected from the base sequence. U7
and U23 of the bulges are in the major groove and form
the two U:A:U base pairs adjacent to each other at the
center of the aptamer, whereas U8 and C24 are flipped-
out into the minor groove. The RNA duplex usually takes
Figure 7. Superposition of the Twenty Final Structures of the Ap- on an A-form structure and its major groove is narrow.
tamer Complexed with Two Argininamide Molecules The formation of the two base triples in the complex
Superposition with respect to all heavy atoms (A) and heavy atoms serves to widen the major groove to create space for
of the Tat binding sites (B). G9:C28, green; U7:A10:U27, red; accommodation of two argininamide molecules. The
U23:A26:U11, yellow; G25:C12, cyan; argininamide 1, magenta; ar-
width of the major groove of the Tat binding sites ofgininamide 2, orange; and others, gray. In (B), U8 and C24 are not
the aptamer, as defined by the nearest phosphorous-shown for clarity.
phosphorous distance, is larger than that of the A form
by ca. 3–6 A˚. In contrast, the width of the minor groove
is smaller than that of the A form by ca. 2 A˚.stoichiometry observed in the titration experiment by
Argininamide 1 and argininamide 2 form hydrogenNMR. Hereafter, the argininamide molecules bound to
bonds with the major groove edges of the G9 and G25sites 1 and 2 are named argininamide 1 and argininamide
bases, respectively. The guanidinium group of argini-2, respectively.
namide 1 is stacked on the C6 base, lying where G9Mostly, only one set of resonances was observed for
would be positioned if it continued the A-form helixthe two argininamide molecules. This indicated that the
through coaxial stacking on C6 (Figure 8C). G9 is pushedresonances of argininamide 1 and argininamide 2 are
aside due to over-twisting, while on the opposite strand,almost completely degenerated, as expected from the
C28-G29 stacking is achieved, as it would in the A-formnearly symmetrical base sequences of the two binding
helix. Similarly, the guanidinium group of argininamide
sites. The degeneration requires the following treatment
2 is stacked on the G22 base, lying where G25 would
on interpretation of the intermolecular NOESY cross
be positioned (Figure 8D). G25 is pushed aside due to
peaks. The intermolecular NOESY cross peaks due to over-twisting, while on the opposite strand, C12-C13
the residues of binding sites 1 and 2 were regarded as stacking is achieved. A U7 base forming a Hoogsteen
those for argininamide 1 and argininamide 2, respec- base pair in the base triple is stacked on the guanidinium
tively. The structural calculation was carried out on the group of argininamide 1 (Figure 8C). Thus, the guanidi-
basis of this interpretation. nium group of argininamide 1 is sandwiched between
two bases, C6 and U7. In the same way, the guanidinium
Structural Determination of the Aptamer- group of argininamide 2 is sandwiched between the
Argininamide Complex G22 and U23 bases (Figure 8D). Similar features were
As the formation of three Watson-Crick A:U, ten Watson- observed for HIV-2 TAR complexed with an argininamide
Crick G:C, one sheared G:A, and two Hoogsteen A:U molecule [19]. The stacking interactions stabilize the
base pairs was confirmed experimentally, correspond- binding of the two argininamide molecules.
ing distance constraints on the hydrogen bonds were H	 of argininamide 1 is located close to the oxygen
included in the structural calculation. Distance con- atoms of the phosphate group between C6 and U7 (ca.
straints on hydrogen bonds between argininamide 1 and 2.7–3.1 A˚). Similarly, H	 of argininamide 2 is located
G9, and between argininamide 2 and G25 were also close to the oxygen atoms of the phosphate group be-
included on the basis of the experimental implications tween G22 and U23 (ca. 2.4–2.9 A˚). These results
mentioned above. Additionally, rather moderate planar- suggest the stabilization of the complex through the
ity constraints were also imposed. Structural calcula- hydrogen bonds between argininamide molecules and
tions gave 20 final structures, which are superimposed these phosphate groups. The formation of the hydrogen
in Figures 7A and 7B for the whole region and for the two bond with the phosphate group is reported for the BIV
Tat binding sites, respectively. The root-mean-square- system [16].
deviations (rmsd) of the 20 final structures versus the
mean structure for heavy atoms were 2.50 
 0.76 A˚ for Stoichiometry of the Aptamer-RG
the whole region and 1.04 
 0.25 A˚ for the two Tat Peptide Complex
binding sites with two argininamide molecules, exclud- The formation of a complex between the aptamer and
the RG peptide was monitored by means of H5-C5 corre-ing flipped-out and the least defined U8 and C24 resi-
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Table 1. NMR Constraints and Structural Statistics for the Aptamer-Argininamide Complex
(A) NMR Constraints
Distance constraints 440
Intraresidue 124
Sequential (i, i  1) 132
Medium to long range  (i, i  2) 86
Intermolecular 98
Dihedral angle constraints 219
 6
 4
 32
 17
0–4 160
Hydrogen bonding constraints 92
Planarity constraints 14
(B) Structural Statistics for Twenty Final Structures
X-PLOR energies (kcal/mol)
Etotal 314 
 5
Ebond 26 
 1
Eangle 198 
 2
Eimproper 21 
 1
Evdw 15 
 2
Enoe 22 
 3
Ecdih 3 
 1
Rmsd from idealized geometry
Bond lengths (A˚) 0.005 
 0.00005
Bond angles () 0.77 
 0.003
Impropers () 0.43 
 0.02
NOE violations
Number of violations greater than 0.3 A˚ 0 
 0
Rmsd of violations (A˚) 0.03 
 0.002
Dihedral angle violations
Number of violations greater than 4 0 
 0
Rmsd of violations () 0.38 
 0.05
Rmsd of 20 final structures versus the mean structure for heavy atoms (A˚)
Whole region 2.50 
 0.76
Two Tat binding sites with two argininamide molecules, excluding U8 and C24 1.04 
 0.25
lation peaks of the aptamer in a series of 1H-13C HSQC trast to the binding of two argininamide molecules per
aptamer. This difference will be discussed below.spectra during titration. The free and bound forms of
the aptamer were found to be in slow exchange on the
NMR time scale. Fast exchange was observed in the Similarity between the RG Peptide-Bound and
Argininamide-Bound Forms in the Aptamercase of the binding of argininamide. This difference is
expected from the very strong binding of the RG peptide Structure and Intermolecular Contacts
Figure 9B shows the chemical shift perturbations of theto the aptamer (dissociation constant of 109 M). The
stoichiometry of the aptamer-RG peptide complex was H5-C5 correlation peaks of the aptamer in the 1H-13C
HSQC spectrum upon binding of the RG peptide. Thedetermined by tracing the changes in the intensities of
cross peaks during titration. The decrease in the intensi- pattern of the perturbations is very similar to that ob-
served upon the binding of argininamide (Figure 4B).ties of several cross peaks representing the free form
of the aptamer is plotted as a function of the molar ratio Similarity of the pattern of the perturbations was ob-
served for other correlation peaks (data not shown).of the RG peptide to the aptamer in Figure 9A. The plot
indicates that one RG peptide binds per aptamer. Similar These results indicate that the structural changes and
thus the resultant structure of the aptamer are quitestoichiometry was observed on plotting the increase in
the intensities of the cross peaks representing the bound similar for RG peptide-bound and argininamide-bound
forms. The affinity between the aptamer and the RGform of the aptamer (data not shown). This is consistent
with the biochemical finding that another peptide, peptide is almost comparable to that between the ap-
tamer and Tat, the difference in dissociation constantclosely related to the RG peptide, binds to the aptamer in
a one to one stoichiometry [23]. Frankel and coworkers being only one order. Therefore, it is expected that the
structure of the aptamer for the Tat-bound form is alsodesigned RNAs in which the two Tat binding sites of
BIV TAR are arranged in a symmetrical manner, as in similar to that for the argininamide-bound form deter-
mined in this study.our aptamer. They found the binding of two peptides of
BIV Tat to some of these RNAs [44]. Thus, the difference It is notable that the aptamer-RG peptide complex
gives NOESY cross peaks that are quite comparable toin the stoichiometry between our aptamer and their
RNAs is noteworthy. the intermolecular NOESY cross peaks observed for the
aptamer-argininamide complex (Figures 9C–9E). The as-The binding of one RG peptide per aptamer is in con-
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Figure 8. Views of a Representative Struc-
ture of the Aptamer Complexed with Two Ar-
gininamide Molecules
Stereo side views of whole region (A) and the
Tat binding sites (B). The same coloring as in
Figure 7 is applied. Phosphorus atoms are
traced by thin gray lines. Top (left) and side
(right) views of U7:A10:U27, G9:C28, U8,
C6:G29, and argininamide 1 (C), and those of
G22:C13, C24, G25:C12, U23:A26:U11, and
argininamide 2 (D).
signments of the cross peaks for the aptamer-peptide ical shifts of the cross peaks in Figures 9C–9E suggest
strongly that the amino acid residues that give thesecomplex were tentatively made by comparing the pat-
terns of the cross peaks between the two complexes. cross peaks are arginine ones.
For the aptamer-peptide complex, intermolecularThe assignments are consistent with both partially ac-
complished sequential assignments for the aptamer- contacts with the arginine residues were observed for
two separate moieties of the aptamer, the C6:G29 andRG peptide complex and the results of analysis of the
chemical shift perturbations for the aptamer-peptide G22:C13 base pairs, as in the case of the aptamer-
argininamide complex. It is impossible that a single argi-complex, as shown in Figure 9B, for example. The chem-
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nine residue of the peptide interacts with these two
separate moieties. It is thus supposed that two different
arginine residues of the peptide interact with these moi-
eties, respectively. The similarity in the patterns of the
intermolecular contacts between the two complexes im-
plies that the two arginine residues of the peptide inter-
act with the aptamer in the same way as two argininam-
ide molecules interact with the aptamer. This explains
the experimental finding that one peptide molecule
binds per aptamer, while two argininamide molecules
bind per aptamer.
The Origin of the High Affinity of the Aptamer
The combination of structural studies on the aptamer-
argininamide and aptamer-peptide complexes suggests
the origin of the high affinity of the aptamer to Tat. The
aptamer binds Tat 100 times more strongly than TAR.
Simultaneous interactions of the aptamer at two sites,
sites 1 and 2, with two different arginine residues of
the arginine-rich region of Tat are supposed to be the
primary reason for the high affinity. Double interactions
could enhance the affinity by as much as the square of
the binding constants, if each interaction is perfectly
achieved, respectively [44]. Practically, it has been re-
ported that by joining DNA binding domains covalently,
the affinity to the multiple binding sites increases by
two or three orders of magnitude [45, 46]. The 100-fold
enhancement of the affinity observed for our aptamer
is reasonable in this sense.
The ability of the aptamer to form two adjacent U:A:U
base triples with the Hoogsteen base pairs in the central
portion is crucial for achieving the simultaneous interac-
tions, because the widening of the major groove on the
formation of the two adjacent base triples is indispens-
able for creating the space to accommodate two bulky
arginine residues and probably also several residues
linking them. The major groove of the aptamer-argini-
namide complex is wider than that of the A form. The
major groove may be able to become even wider when
the aptamer needs to accommodate the two arginine
and joining residues of Tat. The two adjacent U:A:U
base triples at the center may serve to confer such
deformability on the aptamer.
Hoogsteen base-paired U residues of the base triples
contribute to stabilization of the complex through stack-
ing interactions with the guanidinium groups of the argi-
nine residues at the two sites, respectively. The impor-
tance of the formation of the Hoogsteen base pairs is
consistent with the biochemical data revealing that the
replacement of A10 and A26 by 7-deaza analogs, which
cannot accept the Hoogsteen hydrogen donor, abolish
the binding of the Tat peptide [23].
Future Prospects
When the symmetric arrangement of the two Tat binding
sites of the aptamer is considered, it is assumed that
Figure 9. Interactions of the Aptamer with the RG Peptide
(A) Normalized changes of the intensities of the H5-H6 correlation
peaks of the aptamer in the free form as a function of the molar pH 6.5; the assignments are labeled with the residue numbers. The
ratio of the RG peptide to the aptamer at 35C and pH 6.5. Circles, intermolecular NOESY cross peaks between H/H/H of arginine
C6; squares, U11; diamonds, U27; and triangles, C30. residues of the RG peptide and imino protons of the aptamer in H2O
(B) H5-C5 correlation peaks in the 1H-13C HSQC spectra of the free at 1C (C), and those between H/H/H and H6/H8 (D) and H5 (E)
(gray) and RG peptide-bound (black) aptamers in H2O at 35C and of the aptamer in 2H2O at 35C are shown.
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described previously [49]. The lyophilized aptamer was dissolvedtwo arginine residues of a single peptide bind to the
in 10 mM sodium phosphate buffer (pH 6.7) containing 30 mM NaCl,binding sites in a symmetric way. To achieve this, it may
0.1 mM EDTA, and 3 mM NaN3. DSS was used as an internal chemicalbe required that the two arginine residues are separated
shift reference. The concentration of the aptamer was 1.7 mM.
by at least several residues along the primary peptide The aptamer-argininamide complex was prepared by the addition
sequence and that the peptide forms a turn structure for of a concentrated argininamide (Sigma) solution to the RNA aptamer
solution step by step. The aptamer-peptide complexes were pre-these arginine residues to be arranged symmetrically.
pared in the same way.The complex formation of the aptamer with a penta-
peptide, RKKRR, was monitored by NMR. It turned out
NMR Spectroscopythat the free and bound forms of the aptamer were in
NMR spectra were recorded with a Bruker DRX600 spectrometer
slow exchange on the NMR time scale and that one equipped with a quadruple-resonance probe with X, Y, and Z gradi-
pentapeptide bound per aptamer (data not shown), as ents. The following NMR spectra were recorded for the aptamer-
exactly observed for the binding of the RG peptide. The argininamide complex (aptamer:argininamide  1:4): NOESY, 13C-,
15N-filtered NOESY, TOCSY, 31P-decoupled DQF-COSY, 1H-31Ppentapeptide corresponds to the first 5 residues of the
HetCor with suppression of 1H-1H passive coupling, spin echo differ-RG peptide and also corresponds to the residues 49–53
ence constant time 1H-13C HSQC [50], 13C-edited NOESY-HSQC [51],of Tat. The result suggests that either R49 and R52 or
15N-edited NOESY-HSQC [52], HCCH-COSY, HCCH-TOCSY, and
R49 and R53 may be the residues making simultaneous HNN-COSY spectra. Spectra were processed with Capp/Pipp/
double interactions with the aptamer. It is notable that Stapp [53]. A similar set of spectra was obtained for the aptamer-
R52 and R53 of Tat are known to be critical for binding peptide complex (aptamer:peptide  1:1.5).
to TAR [18, 47, 48]. Structural determination of the ap-
Distance Constraintstamer-peptide complexes is currently being challenged
Interproton distances were calculated with the NOESY spectrumin our laboratory.
with a mixing time of 50 ms, as described previously [54]. FourAs discussed previously, the RNA structure of the RG
hundred and forty distance constraints (124 intraresidue, 132 se-
peptide-bound form and presumably that of the Tat- quential, 86 medium- to long-range, and 98 intermolecular ones)
bound form also are close to the RNA structure of the were obtained for the aptamer-argininamide complex.
On the basis of experimental confirmation (see Results and Dis-argininamide-bound form determined in this study.
cussion), hydrogen bond constraints were included for three Wat-Therefore it may be possible to design new RNAs that
son-Crick A:U base pairs, ten Watson-Crick G:C base pairs, oneinhibit Tat or to develop RNA biosensors for Tat by
sheared G:A base pair, and two Hoogsteen A:U base pairs. Hydro-mutating the current RNA aptamer in light of its eluci-
gen bond constraints between the aptamer and argininamide were
dated structure, without having the detailed structural also included.
information on Tat.
Dihedral Angle Constraints
Dihedral angle constraints for the  torsion angle were derived fromBiological Implications
3JH5-P and 3JH5″-P couplings [28, 55]. The s of the G3, A4, G5, G15,
A19, and G21 residues were constrained to 180 
 20. For the otherThe Tat protein of HIV plays a critical role in viral replica-
residues,  was left unconstrained.
tion. The development of effective inhibitors of Tat could Dihedral angle constraints for the  torsion angles were derived
lead to gene therapy. We isolated an RNA aptamer that from 3JH4-H5 and 3JH4-H5″ couplings [28, 55]. The s of the G2, C13,
binds to Tat 100 times more strongly than the authentic G16, and A17 residues were constrained to 60 
 20. For the other
residues,  was left unconstrained.TAR RNA. The aptamer functions as a decoy molecule
Dihedral angle constraints for the , and endocyclic 0, 1, 2, 3,for Tat and thus inhibits the action of Tat both in vitro and
and 4 torsion angles were derived from 3JH1-H2 and 3JH3-H4 couplingsin vivo. Structural basis of the highly efficient trapping of
[28, 54, 55]. The  and endocyclic 0-4 torsion angles of all theTat by the aptamer was elucidated by this study.
residues, except for G1, G3, U7, U8, U23, and C24, were moderately
The aptamer exhibits unique structure when it binds constrained, leaving the sugar free to take on any conformation
the analog of Tat. The formation of two adjacent U:A:U without an energy penalty between C2-exo and C4-exo including
base triples was observed for the first time at the central C3-endo in a pseudorotation cycle. In the same way, those of the
U7, U8, U23, and C24 residues were constrained between O4-endoportion of the aptamer, which widens the major groove
to C3-exo including C1-exo and C2-endo. Those of the G1 andto make space for the accommodation of the analog. The
G3 residues were left unconstrained.aptamer makes the interactions with two arginine residues
Dihedral angle constraints for the  torsion angle were derived
of the analog at both sides of the central two base triples. from 3JC2-P and 3JH3-P couplings [28, 50, 55]. The s of G9, G16, A18,
The simultaneous double interactions of the aptamer and A19 were constrained to 145 
 20, those of A4, G5, C14,
could explain its extremely high affinity to Tat. A17, C20, G21, G25, G29, C30, and U31 to 170 
 50, and those
of U7, U8 and U23 to 100 
 25. For the other residues,  wasThe elucidation of key elements of the aptamer to
left unconstrained.exhibit high affinity at atomic resolution greatly enhances
No dihedral angle constraints were used for the  and  torsionthe rational design of more effective inhibitors of Tat.
angles.Moreover, the strategy to have simultaneous double
interactions with the target protein through two symmet- Structure Calculation
rically arranged binding sites may be applicable to some Structure calculations were carried out using distance and dihedral
other RNA-protein systems utilizing the arginine-rich angle constraints using a simulated annealing protocol supplied
with X-PLOR v. 3.8 [56] on an O2 workstation (Silicon Graphics).motif in order to accomplish high affinity.
Planarity constraints were imposed for the G9:C28 base pair and
the guanidinium group of argininamide 1, and also for the G25:C12Experimental Procedures
base pair and the guanidinium group of argininamide 2, with the
moderate weight of 4 kcal mol1 A˚2. For the other base pairs,Sample Preparation
planarity constraints with the rather moderate weight of 0.4 kcalNonlabeled and 13C- and 15N-labeled RNA aptamers (34-mer) were
synthesized in vitro by transcription, using T7 RNA polymerase, as mol1 A˚2 were imposed, including for the Hoogsteen A:U base
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